Koukourakis et al. noted the increased expression of the VEGFR2 receptor in patients with endometrial cancer, breast cancer and ovarian cancer, accompanied by the elevated serum levels of VEGF [20]. The gene discussed is VEGFA; the disease is ovarian carcinoma.